Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process

Source:
Barrett's Dysplasia Cancer Task Force - BADCAT
Publisher:
Barrett’s Dysplasia Cancer Task Force (BADCAT)
Publication date:
24 April 2012

Abstract

Esophageal adenocarcinoma (EA) is increasingly common among patients with Barrett's esophagus (BE). This guideline aims to provide consensus recommendations based on the medical literature that clinicians could use to manage patients with BE and low-grade dysplasia, high-grade dysplasia (HGD), or early-stage EA.